Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| UNICEF | OTHER |
| Bill and Melinda Gates Foundation | OTHER |
| Boston University | OTHER |
| Ministry of Health, Zambia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will provide important evidence to the Ministry of Community Development, Mother and Child Health (MCDMCH) and the Ministry of Health (MOH) on how to effectively implement iCCM with a focus on improving both the flow of supplies to CHWs as well as the quality of their supervision and mentorship. The overall aim will be to determine whether improvements in supplies for community health workers (CHWs) and strengthened supervision result in improved early and appropriate treatment for children with malaria, pneumonia, and diarrhea in rural Zambia when compared to CHWs offering iCCM without this logistics and supervision support.
The main objective of this study is to strengthen the delivery of integrated community case management (iCCM) of malaria, diarrhea, and pneumonia in Chadiza and Chipata Districts of Eastern Province, through mHealth supported improved supply chain management of iCCM commodities and enhanced supportive supervision of iCCM-trained CHWs.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | mHealth inventory management and referrals via text messaging plus supportive supervision of CHWs via an mHealth strategy |
|
| Control | Placebo Comparator | ICCM current standard of care with CHWs operating under standard conditions without enhanced inventory management or supportive supervision by mHealth |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| mHealth inventory management | Other | Improved stock management of iCCM commodities using the DHIS2 mHealth platform |
|
| Measure | Description | Time Frame |
|---|---|---|
| Composite percentage of children appropriately treated for malaria, diarrhea, and pneumonia. | Defined as percentage of sick children under five years of age presenting with an i-CCM condition to an i-CCM trained health worker (CHW or a CHA) who received appropriate treatment for an iCCM condition (composite indicator): Appropriate treatment for malaria: received artemisinin-based combination therapy (ACT) for malaria for at least three days or Appropriate treatment for pneumonia: received amoxicillin for pneumonia for at least five days or Appropriate treatment for diarrhea: received zinc in addition to fluid from ORS packet or oral rehydration solution (ORS) liquid or homemade fluid for diarrhea | Through study completion, up to six months |
| Measure | Description | Time Frame |
|---|---|---|
| a) Medicine availability (artemether-lumefantrine) | Defined as percentage of iCCM sites with artemether-lumefantrine in stock during the monthly assessments | Through study completion, up to six months |
| b) Clinical supervision coverage |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Godfrey Biemba, MBChB, M.Sc | Contact | 260974770293 | biemba@bu.edu | |
| Boniface M Chiluba, B.Sc, M.Sc | Contact | 260977820763 | chiluboni@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Godfrey Biemba, MBChB, M.Sc | ZCAHRD and Boston University | Principal Investigator |
| David Hamer, MD | Boston University | Principal Investigator |
| Boniface M Chiluba, B.Sc, M.Sc |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chadiza and Chipata Districts | Recruiting | Chipata | Eastern Province | Zambia |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32509293 | Derived | Biemba G, Chiluba B, Yeboah-Antwi K, Silavwe V, Lunze K, Mwale RK, Hamer DH, MacLeod WB. Impact of mobile health-enhanced supportive supervision and supply chain management on appropriate integrated community case management of malaria, diarrhoea, and pneumonia in children 2-59 months: A cluster randomised trial in Eastern Province, Zambia. J Glob Health. 2020 Jun;10(1):010425. doi: 10.7189/jogh.10.010425. |
Not provided
Not provided
The investigators will make the data available to outside parties upon receipt of an appropriate request detailing specific aims and an acceptable analysis plan.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008288 | Malaria |
| D003967 | Diarrhea |
| D011014 | Pneumonia |
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D011528 | Protozoan Infections |
| D010272 | Parasitic Diseases |
| D007239 | Infections |
| D000096724 | Mosquito-Borne Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D008722 | Methods |
| ID | Term |
|---|---|
| D008919 | Investigative Techniques |
Not provided
Not provided
| OTHER_GOV |
| Ministry of Community Development, Mother and Child Health | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
| Supportive supervision | Other | Strengthening of supportive supervision using DHIS2 |
|
|
| ICCM current standard of care | Other | ICCM implementation as per current practice without mHealth interventions |
|
|
Defined as proportion of CHWs who received at least one supervisory contact (in person) every 3 months during which a sick child visit or scenario was assessed and coaching provided.
| Through study completion, up to six months |
| c) Virtual supervision coverage (via mobile technology) | Defined as proportion of CHWs who received at least SMS per month from their supervisor reinforcing the appropriate use of the iCCM algorithm for classification and treatment. | Through study completion, up to six months |
| d) Average cost per iCCM contact | Defined as average expenditure per iCCM contact by type of condition | Through study completion, up to six months |
| e) Diagnostic availability | Defined as percentage of iCCM sites with all iCCM diagnostics (malaria rapid diagnostic tests) in stock during the monthly assessments | Through study completion, up to six months |
| f) Medicine availability (amoxicillin) | Defined as percentage of iCCM sites with amoxicillin in stock during the monthly assessments | Through study completion, up to six months |
| g) Medicine availability (ORS) | Defined as percentage of iCCM sites with ORS in stock during the monthly assessments | Through study completion, up to six months |
| h) Medicine availability (Zinc) | Defined as percentage of iCCM sites with Zinc in stock during the monthly assessments | Through study completion, up to six months |
| Zambia Center for Applied Health Research and Development |
| Study Director |
| D000079426 |
| Vector Borne Diseases |
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012141 | Respiratory Tract Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |